• 1.

    Denlinger CS, et al. Survivorship: Introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2014; 12:3445. doi: 10.6004/jnccn.2014.0005

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Arima H, et al. Mortality patterns in hypertension. J Hypertens 2011; 29 (Suppl 1):S3S7. doi: 10.1097/01.hjh.0000410246.59221.b1

  • 3.

    Gudsoorkar P, et al. Onco-hypertension: An emerging specialty. Adv Chronic Kidney Dis 2021; 28:477489.e1. doi: 10.1053/j.ackd.2021.09.011

  • 4.

    Ruf R, et al. Onco-hypertension: Overview of hypertension with anti-cancer agents. JON 2021; 5:5769. doi: 10.1177/23993693211001374

  • 5.

    Sufrin G, et al. Hormones in renal cancer. J Urol 1977; 117:433438. doi: 10.1016/s0022-5347(17)58490-6

  • 6.

    Gandini S, et al. Anti-hypertensive drugs and skin cancer risk: A review of the literature and meta-analysis. Crit Rev Oncol Hematol 2018; 122:19. doi: 10.1016/j.critrevonc.2017.12.003

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Abdel-Qadir H, et al. Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: A systematic review and meta-analysis. Cancer Treat Rev 2017; 53:120127. doi: 10.1016/j.ctrv.2016.12.002

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Lambrechts D, et al. Genetic markers of bevacizumab-induced hypertension. Angiogenesis 2014; 17:685694. doi: 10.1007/s10456-014-9424-7

  • 9.

    Caletti S, et al. Management of VEGF-targeted therapy-induced hypertension. Curr Hypertens Rep 2018; 20:68. doi: 10.1007/s11906-018-0871-1

  • 10.

    Ketch T, et al. Four faces of baroreflex failure: Hypertensive crisis, volatile hypertension, orthostatic tachycardia, and malignant vagotonia. Circulation 2002; 105:25182523. doi: 10.1161/01.cir.0000017186.52382.f4

    • PubMed
    • Search Google Scholar
    • Export Citation

Oncohypertension: A New Field in the Making

Prakash Gudsoorkar Prakash Gudsoorkar, MD, FASN, FNKF, is Assistant Professor of Medicine with the Division of Nephrology and Kidney C.A.R.E. Program, University of Cincinnati, OH.

Search for other papers by Prakash Gudsoorkar in
Current site
Google Scholar
Restricted access